On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Hospital Clínico Universitario Lozano Blesa

InstitutionResearch output, impact & collaborations

Hospital Clínico Universitario Lozano Blesa is a institution indexed in ScholarIQ from OpenAlex.

What is known about Hospital Clínico Universitario Lozano Blesa?

ScholarIQrecord summary

Hospital Clínico Universitario Lozano Blesa is a research organisation in Zaragoza, ES. OpenAlex records 9,219 works and 373,160 citations for it. 3,464 researchers list it as their most recent affiliation.

How many works does Hospital Clínico Universitario Lozano Blesa have?

ScholarIQindexed works

Hospital Clínico Universitario Lozano Blesa has 9,219 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Hospital Clínico Universitario Lozano Blesa have?

ScholarIQcitation count

Hospital Clínico Universitario Lozano Blesa has 373,160 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Hospital Clínico Universitario Lozano Blesa?

ScholarIQresearcher count

Hospital Clínico Universitario Lozano Blesa has 3,464 researchers in the ScholarIQ index.

What is the average h-index at Hospital Clínico Universitario Lozano Blesa?

ScholarIQavg h-index

Hospital Clínico Universitario Lozano Blesa has an average h-index of 44 in OpenAlex.

What is the ROR of Hospital Clínico Universitario Lozano Blesa?

ScholarIQror

The ROR for Hospital Clínico Universitario Lozano Blesa is on the source record.

What is the OpenAlex record for Hospital Clínico Universitario Lozano Blesa?

ScholarIQopenalex

The OpenAlex for Hospital Clínico Universitario Lozano Blesa is on the source record.

Who are the most-cited researchers behind Hospital Clínico Universitario Lozano Blesa?

ScholarIQtop researchers by citations
1
Dolores Isla · Lung Cancer Treatments and Mutations
362 works20,072 citations

What are the most-cited papers on Hospital Clínico Universitario Lozano Blesa?

ScholarIQmost cited works
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares
The Lancet Oncology. 20125,545 CitationsOPEN ACCESS
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers
Solange Peters, Rolf A. Stahel, Lukas Bubendorf, Philip Bonomi, Augusto Villegas, Dariusz M. Kowalski, Christina S. Baik, Dolores Isla, Javier de Castro, Pilar Garrido, Achim Rittmeyer, Marcello Tiseo, Christoph Meyenberg, Sanne de Haas, Lisa H. Lam, Michael W. Lu, Thomas E. Stinchcombe
Clinical Cancer Research. 2018231 CitationsOPEN ACCESS

How much of the research on Hospital Clínico Universitario Lozano Blesa is open access?

ScholarIQopen access share
100%OPEN ACCESS
Gold
0%
Green
50%
Hybrid
0%
Bronze
50%
Closed
0%

Related on ScholarIQ

470M+ articles · 14-day free trial